The death of osteocytes by apoptosis in human bone is observed following oestrogen withdrawal by GnRH analogues

The death of osteocytes by apoptosis in human bone is observed following oestrogen withdrawal by GnRH analogues

Bibliografski detalji
Glavni autori:	Tomkinson, A, Reeve, J, Shaw, R, Noble, B
Format:	Journal article
Izdano:	1996

Slični predmeti

The death of osteocytes via apoptosis accompanies oestrogen withdrawal in human bone.
od: Tomkinson, A, i dr.
Izdano: (1996)

The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone.
od: Tomkinson, A, i dr.
Izdano: (1997)

The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone.
od: Tomkinson, A, i dr.
Izdano: (1997)

The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
od: Tomkinson, A
Izdano: (1997)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
od: Madelaine J. Cho-Clark, i dr.
Izdano: (2023-04-01)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
od: Colleen A. Flanagan, i dr.
Izdano: (2017-10-01)

Suppression of puberty with GnRH analogues in adolescents with Gender Dysphoria
od: Julita Poleszak, i dr.
Izdano: (2019-09-01)

Suppression of puberty with GnRH analogues in adolescents with Gender Dysphoria
od: Julita Poleszak, i dr.
Izdano: (2019-09-01)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
od: Martin Stimpfel, i dr.
Izdano: (2015-01-01)

Osteocyte function, osteocyte death and bone fracture resistance.
od: Noble, B, i dr.
Izdano: (2000)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission.
od: Gueorguiev, M, i dr.
Izdano: (2012)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission
od: Gueorguiev, M, i dr.
Izdano: (2011)

The GnRH Pulse Generator
od: Pasha Grachev, i dr.
Izdano: (2016-12-01)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
od: Cota Ana Marcia M, i dr.
Izdano: (2012-04-01)

Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
od: Alamtaj Samsami, i dr.
Izdano: (2020-11-01)

Differential roles of GnRH-I and GnRH-II neurons in the control of the primate reproductive axis
od: Henryk eUrbanski
Izdano: (2012-02-01)

Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders
od: Hemchand K Prasad, i dr.
Izdano: (2012-01-01)

Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria
od: Biggs, M
Izdano: (2021)

Transpharyngeal Exposure of GnRH Neurons
od: Stephanie Constantin, i dr.
Izdano: (2014-03-01)

Epigenetic control of GnRH neurons
od: Joseph Raymond Kurian, i dr.
Izdano: (2013-05-01)

Estrogenic Regulation of the GnRH Neuron
od: Sally eRadovick
Izdano: (2012-04-01)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
od: Raoul Orvieto
Izdano: (2023-01-01)

The role of estrogen in the control of rat osteocyte apoptosis.
od: Tomkinson, A, i dr.
Izdano: (1998)

Evaluating the Efficacy of Treatment with a GnRH Analogue in Patients with Central Precocious Puberty
od: H. Nur Peltek Kendirci, i dr.
Izdano: (2015-01-01)

Sterile abscess formation with two different GnRH analogues: Three case reports
od: Gülin Karacan Küçükali, i dr.
Izdano: (2024-03-01)

Effect of GnRH analogue, buserelin acetate, on semen quality of subfertile male dogs
od: T. P. Ananthapadmanabhan, i dr.
Izdano: (2024-06-01)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
od: Hwu Yuh-Ming, i dr.
Izdano: (2009-03-01)

Different dendritic domains of the GnRH neuron underlie the pulse and surge modes of GnRH secretion in female mice
od: Li Wang, i dr.
Izdano: (2020-07-01)

The role of GABA in the regulation of GnRH neurons
od: Miho eWatanabe, i dr.
Izdano: (2014-11-01)

Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist
od: Nayereh Khadem Ghaebi, i dr.
Izdano: (2018-11-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
od: Mu Lv, i dr.
Izdano: (2022-10-01)

Osteocyte apoptosis and functional strain in bone
od: Noble, B, i dr.
Izdano: (1997)

Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance.
od: Huber, C, i dr.
Izdano: (2007)

#304 : Comparing GnRH Agonist and GnRH Antagonist Protocols for IVF-ET Outcomes in Patients with Endometriosis: A Meta-Analysis
od: Haerin Paik, i dr.
Izdano: (2023-12-01)

Comparing ART outcomes in women with endometriosis after GnRH agonist GnRH antagonist ovarian stimulation: a systematic review
od: Kevin K.W. Kuan, i dr.
Izdano: (2023-07-01)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
od: Erkan Kalafat, i dr.
Izdano: (2022-05-01)

Use of GnRH Agonist in Dogs Affected with Leishmaniosis
od: Michela Pugliese, i dr.
Izdano: (2021-02-01)

Application of Exogenous GnRH in Food Animal Production
od: A. H. M. Musleh Uddin, i dr.
Izdano: (2023-06-01)

Long GnRH Agonist versus GnRH Antagonist Protocols in Women with Endometrioma and Good Ovarian Reserve Undergoing IVF/ICSI Cycles
od: Maryam Eftekhar, i dr.
Izdano: (2023-01-01)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
od: Jifan Tan, i dr.
Izdano: (2023-02-01)